Literature DB >> 22205039

Towards defining a rigidity-associated pathogenic pathway in idiopathic parkinsonism.

R John Dobbs1, André Charlett, Sylvia M Dobbs, Clive Weller, Owens Iguodala, Cori Smee, James Bowthorpe, David Taylor, Ingvar T Bjarnason.   

Abstract

Helicobacter pylori eradication has a differential effect on the facets of idiopathic parkinsonism (IP): brady/hypokinesia improves, but rigidity worsens. Small intestinal bacterial overgrowth is common in IP and has been described as a sequel to Helicobacter eradication. The hyperhomocysteinaemia of IP is, in part, explained by serum vitamin B(12), but the concentration is not explained by Helicobacter status. Moreover, Helicobacter-associated gastric atrophy is uncommon in IP. However, overgrowth both increases B(12) utilization and provides a source of inflammation to drive homocysteine production. It is not a bystander event in IP: clouds of lysosomes are seen in duodenal enterocytes. Its candidature for causality of a rigidity-associated pathway is circumstantial: there are biological gradients of rigidity on natural killer and T-helper blood counts, both being higher with hydrogen breath test positivity for overgrowth.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 22205039     DOI: 10.1159/000332807

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  2 in total

Review 1.  Brain-gut-microbiota axis in Parkinson's disease.

Authors:  Agata Mulak; Bruno Bonaz
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

2.  Augmentation of Autoantibodies by Helicobacter pylori in Parkinson's Disease Patients May Be Linked to Greater Severity.

Authors:  Gunasekaran Suwarnalata; Ai Huey Tan; Hidayah Isa; Ranganath Gudimella; Arif Anwar; Mun Fai Loke; Sanjiv Mahadeva; Shen-Yang Lim; Jamuna Vadivelu
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.